Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus

Lupus. 2016 Oct;25(11):1278-9. doi: 10.1177/0961203316631636. Epub 2016 Feb 11.

Authors

F Farinha¹, E Abrol², D A Isenberg³

Affiliations

¹ Rheumatology Department, Centro Hospitalar do Baixo Vouga E.P.E., Aveiro, Portugal.
² Princess Royal University Hospital (PRUH), King's College Hospital NHS Foundation Trust, London, UK.
³ Centre for Rheumatology, Division of Medicine, University College London - London, UK d.isenberg@ucl.ac.uk.

PMID: 26873650
DOI: 10.1177/0961203316631636

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Biological Products / therapeutic use*
Humans
Lupus Vasculitis, Central Nervous System / drug therapy*
Lupus Vasculitis, Central Nervous System / pathology
Randomized Controlled Trials as Topic
Rituximab / therapeutic use
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Biological Products
Rituximab
belimumab